The Chart of the Day belongs to the building products and equipment company Carlisle Companies (CSL) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest...
/CNW/ -- Global biotechnology leader CSL (ASX: CSL) today announced that Health Canada has authorized HEMGENIX® (etranacogene dezaparvovec), the first and only...
Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among...
Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following...
/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...
CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the...
These vital manufacturers could produce stellar returns.
Carlisle's (CSL) first-quarter 2023 earnings decline 39.7% on a year-over-year basis due to lower sales.
Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on June 1, 2023, to shareholders of record at the close of business on May 17, 2023.